Zenodo (CERN)open access
Diagnosis and treatment of cutaneous adverse effects of targeted therapy, antibody–drug conjugates, and immunotherapy in cancer patients: a national consensus statement by the Spanish Society of Medical Oncology and the Spanish Academy of Dermatology and Venereology
Antiangiogenic drugs, Chemotherapy, Cutaneous toxicity, Dermatological toxicity, Immune checkpoint inhibitors, Targeted therapies
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 161134
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.